AGARWALEYENSEDr. Agarwal's Health Care Limited· Healthcare ServicesHighPositive
Announced Tue, 17 Feb, 2026 · 13:26 IST

Stock exchanges clear amalgamation of eye hospital arm with listed company

Nclt Scheme FiledStrategic Transactions View source PDFExplain this filing

AGARWALEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.1%Reaction day
₹452.90
prior close
₹450.50
announcement price
In-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+1.0%-1.1% vs market
Hospital peers, median of 24sector+1.2%-1.3% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 1.3 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.1
10m
+0.0
15m
+0.1
30m
-0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.1+1.0-1.1+1.2-1.3
Next day
+0.0+1.3-1.3+1.3-1.3
2d
-1.5-0.2-1.3+0.8-2.3
3d
-1.5-0.3-1.2+0.2-1.8
4d
-3.3-0.2-3.1+0.7-3.9
5d
+0.0-1.4+1.5-0.2+0.3
1w
-0.9-1.0+0.1+1.4-2.3
15d
-2.4-6.3+4.0-3.5+1.1
1m
-6.2-9.0+2.8-6.9+0.8
2m
-2.0+3.5-5.5+1.6-3.6
3m
-2.8+4.6-7.4+7.0-9.8
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dr. Agarwal's Health Care (AHCL) has received no-objection letter from NSE on Feb 16 and no-adverse-observations from BSE on Feb 17 for its scheme to merge Dr. Agarwal's Eye Hospital (AEHL) into AHCL. Board had approved the scheme on Aug 27, 2025. Next steps are shareholder and creditor approvals and filing the scheme with NCLT within 6 months.

Likely market impact

Clears key exchange hurdle for the merger; still needs shareholder, creditor and NCLT approvals before completion.